Vivet Therapeutics Announces Multiple Projects Update, Including New VTX-803 Preclinical data To Be Presented At 2021 American Society Of Gene And Cell Therapy Annual Meeting
Retrieved on:
Monday, May 10, 2021
In people with PFIC, liver cells are less able to secrete bile or essential components into the bile.
Key Points:
- In people with PFIC, liver cells are less able to secrete bile or essential components into the bile.
- The disease is estimated to affect one in every 50,000 to 100,000 births in the United States and Europe.
- Six types of PFIC have been genetically identified, all of which are similarly characterized by impaired bile flow and progressive liver disease.
- In PFIC3, cholestasis results from the toxicity of bile in which detergent bile salts are not inactivated by phospholipids, leading to bile canaliculi and biliary epithelium injuries.\n'